* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Sutton Locality
Survey
Document related concepts
Transcript
REQUEST FOR CONTINUATION OF FUNDING FOR PbR EXCLUSION F.A.O: From: Your designation: Your contact details: PbR excluded Drugs Team North West London Commissioning Support Unit E-mail: [email protected] Tel: E-mail: Date: Before providing patient identifiable data below, I can confirm that the patient (or in the case of a minor or vulnerable adult with the parent/legal guardian/carer) has given appropriate explicit consent for sensitive personal information on this form to be passed to the CCG and/or CSU for processing this request for further funding and validating subsequent invoices. Consent given: ☐Yes I would like to request further funding for the following: Drug name: Indication: Ranibizumab ☐ Aflibercept ☐ Macular Oedema secondary to Retinal Vein Occlusion Central ☐ Branch ☐ Patient NHS number: Hospital no: Patient birth year: GP Practice Code: GP Practice Postcode: I herewith provide you with the requested information: 1. This request is for continued treatment of the same eye(s)* ☐ Yes 2. Please confirm which eye(s) is/are to be treated and their current visual acuity (BCVA) ☐Left Eye – BCVA: ☐Right Eye – BCVA: 3. Visual acuity has continued to improve? ☐ Yes 4. Visual acuity has not yet been stable for 3 consecutive months? 7. What is acquisition cost of drug including VAT (if applicable)? ☐ No ☐ No ☐ Yes ☐ No £ /0.5mg injection *A new application is required for: Repeat treatment of the same eye because the visual acuity deteriorates following treatment withdrawal after initial response. Note: Funding will only be re-approved if the patient has shown an improvement of visual acuity Treatment of the other eye I look forward to your response in due course. Document1